- The Journal of Life Sciences

font size

We cannot find the page you are looking for.

We don't have the page you're looking for
Please select one of the pages below.

Hits and Misses by DANIEL S. LEVINE
An analysis of pharma deals shows certain types are better predictors of success than others.
Dishonor Roll by ERIC WAHLGREN
U.S. health system's grade knocked down to a D.
Whether The Couric Effect Is Real, It's Not Enough by DANIEL S. LEVINE
CDC says despite improvements colorectal cancer screening rate remain too low.

Searching For A Bottom
A wild week on Wall Street may change the financial landscape for years to come.
I Want A New Drug by DANIEL S. LEVINE
IDIS Pharmaceuticals has carved out a niche by connecting patients to drugs not yet approved in their countries. Now it's taking its services to the United States.
Tall Order by JOEL MCCORMICK
Can Singapore buy its way to the top of the biotech world with no background in entrepreneurship or science?

Who's got a shoulder when I need to cry?
Maternal mortality rates improve, but well off pace to meet Millennium Development Goals.
Paying A Premium
Cost of family health insurance rises to $12,680 as workers face higher deductibles.
Google's Big Record Deal by ERIC WAHLGREN
If the search giant is successful in its healthcare venture, it could spark a nationwide electronic medical records network.

Billion Dollar Copycats
Generic drugmakers tout billions in savings that could be realized with the introduction of biogenerics.
Thinking Small by LORI ANDREWS AND JULIE BURGER
U.S. patent officials and other regulators must get up to speed on the intricacies of tiny particles to avoid hindering the growth of nanotechnology.
Untethering Innovation by BRADFORD PLUMER
One year before a new president takes office, Congress lies low, but bills on patents, biologics, genetics, and a host of other issues could still affect R&D.

They Don't Call, They Don't Write by DANIEL S. LEVINE
Ethicists says investigators should share results with research volunteers in their studies.
An Ounce Of Prevention by DANIEL S. LEVINE
Biomedical research costs money, but it promises to fix the healthcare mess, save billions in the long run, and cure people even before they get sick.
Public or Private? by PETER J. PITTS
Commercial confidential information need to be protected to ensure innovation.

Gas Guzzlers by ERIC WAHLGREN
Scientists in New Zealand move closer to curbing global warming with a vaccine for sheep flatulence.
Photo Essay: Gimme Shelter
A lab building boom is underway in California thanks to money raised by the state's stem cell agency. The race is on as 12 institutions must complete building their state-of-the art research facilities in just two years.
Gimme Shelter by ERIC WAHLGREN
A lab building boom is underway in California thanks to money raised by the state's stem cell agency. The race is on as 12 institutions must complete building their state-of-the art research facilities in just two years.

Wheeled Away by ERIC WAHLGREN
Golf cart injuries surge along with the vehicles' use on and off the links.
Guinea Pig Zero Speaks
Podcast: October 2008
It Ain't Rocket Science
Report offers advice to the next president on filling key science and technology positions and urges him to do so quickly.

Oddities and Wonders
A news round-up of the bizarre from the world of the life sciences
TJOLS-TV
The life sciences in the news
What's So Funny About Cancer
Mike Schneider interviews comedian Robert Schimmel on his fight with non-Hodgkin's lymphoma.

» See more